Paris-based Aqemia, which aims to scale drug discovery by combining quantum physics algorithms and AI, has raised a €30M Series A (Patricia Allen/EU-Startups)
Patricia Allen / EU-Startups: Paris-based Aqemia, which aims to scale drug discovery by combining quantum physics algorithms and AI, has raised a €30M Series A — Pharmatech startup Aqemia has just raised €30 million in a new funding round. The Parisian startup is generating a pioneering drug discovery pipeline …
Patricia Allen / EU-Startups:
Paris-based Aqemia, which aims to scale drug discovery by combining quantum physics algorithms and AI, has raised a €30M Series A — Pharmatech startup Aqemia has just raised €30 million in a new funding round. The Parisian startup is generating a pioneering drug discovery pipeline …
This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/H6HQO6H4L5NBRLZHVPAIMIBV44.jpg){kind=small}
